Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Penile Allotransplantation
NCT02395497Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Jun 2014
- Primary completion
- Jun 2034
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in Penile injury and micropenis, sponsored by Johns Hopkins University. Primary endpoint: Allograft Survival at 5 years. Started Jun 2014; status: recruiting.
02
Conditions
Penile injurymicropenis
Beyond the preview
Go deeper on NCT02395497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02395497.